Brincidofovir in paediatric patients with life-threatening DNA virus infections after multiorgan transplants

Trial Profile

Brincidofovir in paediatric patients with life-threatening DNA virus infections after multiorgan transplants

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Brincidofovir (Primary)
  • Indications Adenovirus infections; Cytomegalovirus infections; Epstein-Barr virus infections; Polyomavirus infections; Varicella zoster virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2014 New trial record
    • 31 Jul 2014 Results presented at World Transplant Congress 2014, according to a Chimerix media release.
    • 31 Jul 2014 Results presented at the World Transplant Congress 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top